Respiratory Therapists as COPD Educators

Similar documents
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital

TACKLING COPD READMISSIONS. Wendy Presley RN

Breaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More

2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters

Fact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Chronic Obstructive Pulmonary Disease (COPD) KAREN ALLEN MD PULMONARY & CRITICAL CARE MEDICINE VA HOSPITAL OKC / OUHSC

Chronic Obstructive Pulmonary Disease (COPD) Clinical Guideline

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

Commissioning for Better Outcomes in COPD

COPD Treatable. Preventable.

CARE OF THE ADULT COPD PATIENT

Background. Background. Background 3/14/2014. Conflict of Interest Statement:

North Region Respiratory Care Conference April 11-13, 2016 Rochester MN. Improving COPD Outcomes by Improving Care Transition

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Slide 2. Slide 3 Respiratory Therapists Making a Difference. Disclosure. Improving Care Transition for COPD Patients: A New Priority

Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center

9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR

Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR

2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

Asthma: Evaluate and Improve Your Practice

Using Pay-for-Performance to Improve COPD Care MHC64474 SV64474

Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018

Chronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc..

American Thoracic Society (ATS) Perspective

COPD Update. Muhammad Talha Khan MD. COPD Exacerbations. COPD Clinical Importance. COPD Pathophysiology. Overview/Objectives

MULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient

Management of Acute Exacerbations of COPD

2015 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING 10/16/2018 DISCLOSURES I have no financial or other disclosures

Disclosure and Conflict of Interest 8/15/2017. Pharmacist Objectives. At the conclusion of this program, the pharmacist will be able to:

Provider Respiratory Inservice

Pulmonary Rehabilitation

COPD: From Hospital to Home October 5, 2015 Derek Linderman, MD Associate Professor COPD Center Pulmonary Nodule Clinic

COPD in Transitions of Care an opportunity for Pharmacists

2017 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

Research in Real Life

Managing COPD Learning Collaborative

COPD Education for Clinic RNs and MA s 6/28/18

Chronic Obstructive Pulmonary Disease (COPD) Measures Document

Clinical Practice Guideline: Asthma

ACO Impact on Transitions of Care: Witnessing the Improved Value of Re Engineering Communication at All Points of Care

COPD: Current Medical Therapy

Current Approaches to Asthma & COPD

รศ. นพ. ว ชรา บ ญสว สด M.D., Ph.D. ภาคว ชาอาย รศาสตร คณะแพทยศาสตร มหาว ทยาล ยขอนแก น

Chronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc.

OBSERVATION UNIT ASTHMA PATHWAY OUTLINE Westmoreland Hospital PAGE 1 OF 5

Chronic Obstructive Pulmonary Disease (COPD).

OMICS International Conferences

Defining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist

Chronic Obstructive Pulmonary Disease Guidelines and updates

CLINICAL USE CASES FOR RMT

Advancing COPD treatment strategies with evidencebased. 17:15 19:15 Monday 11 September 2017 ERS 2017, Milan, Italy

CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease

Pathway diagrams Annex F

Patient Care Transitions in COPD: Improving Collaboration Between Inpatient and Outpatient Providers to Reduce Readmissions

Pulmonary Rehabilitation. Palmetto GBA, Jurisdiction 11 MAC Provider Outreach and Education

11/27/18. Challenges in Pulmonary and Critical Care: COPD So Much is New! Faculty. Disclosures

H2H Early Follow-up Challenge: See You in 7. Webinar #1 Thursday, March 3, :00 pm 4:00 pm ET. Welcome

2017 GOLD Report. Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017

Asthma COPD Overlap (ACO)

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton

Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health

COPD: GOLD guidelines Ijlal Babar, MD Medical Director Pulmonary CCM, Pulmonary Hypertension Center SRHS

Optimizing Inhaler Technique

Minimum Competencies for Asthma Care in Schools: School Nurse

COPD: Preventable and Treatable. Lecture Outline. Diagnosis of COPD. COPD: Defining Terms

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

COPD: A Renewed Focus. Disclosures

Lecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)

Improving access to pulmonary rehabilitation through Medicare Benefit Scheme subsidies

Ron Hosp, MS-HSA, RRT Regional Respiratory Specialist. This program has been approved for 1 hour of continuing education credit.

Truth or Consequences: Making Choices that Impact Patient Care C A L G A R Y A P R I L

Managing Chronic Obstructive Pulmonary Disease (COPD) Learning Collaborative

Changing Healthcare Forever mycopd

Over the last several years various national and

Journal of the COPD Foundation

WEBINAR. Difficult-to-treat and severe asthma: changing the paradigm

COPD: Applying New Guidelines to Optimizing Evaluation and Treatment

TORCH: Salmeterol and Fluticasone Propionate and Survival in COPD

COPD GOLD Guidelines & Barnet inhaler choices. Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust

Beyond the Next Breath: Controlling Costs and Maximizing COPD Outcomes

Design - Multicentre prospective cohort study. Setting UK Community Pharmacies within one CCG area within the UK

Public Dissemination

Confronting the Challenges of COPD. What is New in The Approaches to Diagnosis, Treatment, and Patient Outcomes

Joint Session ACOFP and AOASM: Exercise Induced Asthma. Bruce Dubin, DO, JD, FCLM, FACOI

BTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012

Bronchodilator Delivery and Nebuliser Trials in Adults

Nasal High Flow Humidification with or without Oxygen for COPD Management. Shereen Bailey, RCP, RRT, NPS

National Asthma Educator Certification Board Detailed Content Outline

MANAGING COPD AT HOME. Karla Schlichtmann, RRT

Presented by the California Academy of Family Physicians 2013/California Academy of Family Physicians

Yorkshire & Humber Respiratory Programme Report

Disclosures. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease (COPD)

USAID Health Care Improvement Project

Chronic obstructive pulmonary disease

Yorkshire & Humber Respiratory Programme Report

Transcription:

Respiratory Therapists as COPD Educators Becky Skinner, RRT-ACCS, CHT, MBA 38 th Annual Respiratory Care Seminar October 2018 1

Disclosure Statement I have no financial relationship with any manufacturer of any commercial product and/or provider of commercial services discussed in the CME activity. 2

Objectives Define the challenges of providing care for patients with COPD Review the Hospital Readmission Reduction Program Discuss newly implemented respiratory therapy COPD education initiative at University of Iowa Health Care 3

Chronic Obstructive Pulmonary disease (COPD) Definition: Chronic Obstructive Pulmonary Disease is a common, preventable and treatable disease characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities, usually caused by significant exposure to noxious particles of gases. Diagnosis: Signs and symptoms Hx exposure to lung irritants Family history Spirometry COPD Pearls. Spirometry is to COPD as a blood pressure cuff is to hypertension. Pierson, D. (2006). Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources. Respiratory Care, 277-88. https://www.ncbi.nlm.nih.gov/pubmed/16533418 4

COPD Health Concern Global prevalence 11.7% Leading cause of morbidity & mortality in USA 15 million cases diagnosed Estimated 13 million more undiagnosed Over 10 million provider office visits 1.5 million ED visits 700,000 hospitalizations each year in the U.S. Estimated 138,080 deaths/year Direct and indirect annual cost > $52 billion Aggregate charges for inpatient stays for COPD or bronchiectasis among patients aged 18 y. Nationwide sample 2001-2012 Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018 Chest 2015; 147(4): 989-998 https://www.clinicaladvisor.com/copd-information-center/patients-with-copd-lack-access-to-care/article/496432/. 5

Chest 2015; 147(4): 989-998 6

Hospital Readmissions Reduction Program (HRRP) Penalize hospitals for excess 30 day readmissions when compared to expected levels of readmissions. Penalty - up to 3% of Medicare payments 2015 COPD added Flaw policy penalizes hospitals for unrelated admissions that occur within 30 days of the original hospitalization. Risk Factors for Increased 30-day All-cause Readmission Rates for COPD Krumholz, H.. (2013). Post-Hospital Syndrome An Acquired, Transient Condition of Generalized Risk. N Engl J Med, 100-102. https://www.nejm.org/doi/full/10.1056/nejmp1212324 Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-1428[Erratum, N Engl J Med 2011;364:1582.] (Payer_COPD_Understanding and Reducing Hospital Readmissions provided by GSK) 7

History in diagnosing COPD Lack of spirometry skewing the numbers? Clinical Practice Guidelines are not followed If it smells like COPD (smoker), it must be COPD train of thought Of the 55% primary care physicians actually aware of major COPD guidelines, only 25% used them to guide decision making How prevalent is the problem? 30-50% of diagnosed COPD patients have not had spirometry (Foster, Yawn, Maziar, Jenkins, Rennard, & Casebeer, 2007 8

Misdiagnosis impact 6,018 patients admitted with COPD 21% had confirmatory spirometry in prior 2 years 8.4% had spirometry during hospitalization 69% (n=270) confirmed COPD dx 31% (n=120) COPD dx refuted by PFTS 43% (n=54) without COPD had persistent COPD dx on discharge 26% (n=32) oral steroids 31% (n=39) LABA/LAMA Chest. 2015 Feb;147(2):369-376. doi: 10.1378/chest.14-0672 Respir Care. 2016 Sep;61(9):1192-200. doi: 10.4187/respcare.04647. Epub 2016 May 10 Int J Chron Obstruct Pulmon Dis. 2013;8:545-9. doi: 10.2147/COPD.S45693. Epub 2013 Nov 12. https://doi.org/10.2147/copd.s139919 9

Why isn t spirometry being used? A clinician s prospective Difficult to perform in hospitalized patients It can wait until after discharge I m sure it was already done if they were diagnosed with it I don t know how to read the stupid things I know COPD when I see it Guidelines, what guidelines? Patient is a smoker, don t need spirometry 10

Patient knowledge of their COPD How bad is it? 82% claimed to understand disease and available treatments 45% were knowledgeable about COPD symptoms. 44% knowledgeable about causes of COPD 35% knowledgeable about medications 27% aware of importance of preventing symptoms (exacerbation) (Dhand, et al., 2018, Pothirat, Chaiwong, Phetsuk, Pisalthanapuna, Chetsadaphan, & Choomuang, 2015) 11

Where does education start if it even happens? (Dhand, et al., 2018) 12

Inhaler technique is a high priority Drugs don t work in people who don t take them C. Everett Kopp, MD When a treatment is given by the inhaled route, the importance of education and training in inhaler device technique cannot be over-emphasized. Choice of inhaler device individually tailored and depend on: Access Cost Prescriber Patient s ability and preference Han MD, et al. Lancet Respir Med. 2016; 4:473-526; Pothiratet al, Respir Care Journal,2015; Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018; Melani AS, et al. Respir Med. 2011; 105:930-938; Molimard M, et al. J Aerosol Med. 2003;16:249-254; Souza ML, et al. J Bras Pneumol. 13 2009;35:824-831

Respiratory Therapy s role is evolving Bridging the gap Advocate and Educate Physicians PFTs EBP Medications Pulmonary Rehab Referrals Patients Disease process Self management Risk reduction Stress management Inhaler technique Action plan Breathing techniques (Foster, Yawn, Maziar, Jenkins, Rennard, & Casebeer, 2007) 14

Defining the problem at UIHC Lack of knowledge and utilization of EBP Increasing complexities in pharmacologic therapy for COPD Patient education lacking Pulmonary rehab and smoking cessation opportunities missed No standard COPD admission order set No COPD bronchodilator protocol 15

University of Iowa Health Care Respiratory Therapy Driven Education Phase I Outpatient Collaboration Outpatient and inpatient component Outpatient implemented 1 st Staff education Documentation template/script Order creation Inhaler education tool kit Note documentation Inhaler inspiratory flow w/resistance training 16

Device selection & Peak Inspiratory Flow Rate Importance of peak inspiratory flow rate (PIFR) 1 in every 4 achieved PIF <60 L/min using medium-low resistance, yet 70% were receiving meds via DPIs. More than 1/3 of commonly prescribed COPD inhalers require optimal PIF to activate effectively. 60% of patients with mild COPD fail to reach adequate PIF for a high resistance device. MDI/Respimat Diskus HandiHaler Amin A, et al. J Hosp Med. 2016; 11 (Suppl 1): Abstract 94; Sharma G, et al. J Hosp 17 Med. 2016; 11 (Suppl 1): Abstract 135

Phase II - Inpatient EPIC report identifying COPD admissions Core therapists COPD Educator Course Education 3-4 sessions Collaboration with multi-disciplinary team Follow-up post discharge Data collection 18

Inpatient education workflow Patient checklist Medical record review Educational assessment General information folder Instructional handouts Action plan Resource links Contact numbers Individualized patient educational sessions Data collection 19

Inpatient education sessions Table-top display flip book Simplified patient view Detailed therapist script Sections: COPD and Symptoms COPD Medications COPD Triggers Self-Management Strategies Evaluation and demonstration of inhalers 20

Inpatient education Collaboration Physician contact Insufficient PIFR Pulmonary function testing needs Stop-Bang Sleep Apnea Score Home oxygen needs Pulmonary rehab consult Smoking cessation consult Obstructive Pulmonary Disease Clinic Follow-up Social work DME 21

Next steps Instructional videos on inhaler and breathing techniques Pharmacy evaluating inhalers on formulary COPD exacerbation admission order set RT COPD bronchodilator protocol Expand to include asthma 22

Lessons learned Network Expect changes and adapt Anticipate resistance Choose the right people Questions? 23